Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-08-20 Purchase |
2024-08-21 4:32 pm |
EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director |
2,567 | $7.79 | $19,997 | 9,967 (Direct) |
View |
2024-08-21 Purchase |
2024-08-21 4:01 pm |
EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director |
5,000 | $7.95 | $39,750 | 13,150 (Direct) |
View |
2024-08-19 Purchase |
2024-08-21 4:01 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director |
12,500 | $7.98 | $99,750 | 16,500 (Direct) |
View |
2024-08-16 Purchase |
2024-08-20 4:04 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director |
3,173 | $7.88 | $25,003 | 224,524 (Indirect Direct) |
View |
2024-07-12 Sale |
2024-07-16 4:24 pm |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
11,625 | $10.06 | $116,995 | 11,625 (Direct) |
View |
2024-06-03 Sale |
2024-06-04 4:28 pm |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
11,625 | $10.3 | $119,705 | 23,250 (Direct) |
View |
2024-05-14 Sale |
2024-05-16 5:19 pm |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
11,625 | $12.65 | $147,045 | 34,875 (Direct) |
View |
2024-05-06 Purchase |
2024-05-08 4:23 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner |
850,000 | $11.86 | $10,081,721 | 8,325,000 (Indirect) |
View |
2024-04-18 Purchase |
2024-04-22 4:00 pm |
EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner |
581,765 | $18.03 | $10,489,446 | 7,475,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-19 Other |
2025-03-20 4:06 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
20,000 | $6.155 | 120,151 (Direct) |
View |
2025-02-09 Exercise |
2025-02-11 6:19 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
5,834 | $0 | 75,550 (Direct) |
View |
2025-02-09 Exercise |
2025-02-11 6:19 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director |
20,000 | $0 | 332,325 (Direct) |
View |
2025-02-09 Exercise |
2025-02-11 6:19 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
7,000 | $0 | 100,151 (Direct) |
View |
2025-02-09 Tax Withholding |
2025-02-11 6:19 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
2,055 | $6.495 | 100,151 (Direct) |
View |
2025-01-08 Option Award |
2025-01-08 4:14 pm |
N/A 2035-01-08 |
EyePoint Pharmaceuticals Inc. | EYPT | Sanders Reginald J. Director |
80,000 | $0 | 80,000 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:05 pm |
2026-01-03 2035-01-03 |
EyePoint Pharmaceuticals Inc. | EYPT | Hassan Fred Director |
40,000 | $0 | 40,000 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:05 pm |
2026-01-03 2035-01-03 |
EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director |
40,000 | $0 | 40,000 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:04 pm |
2026-01-03 2035-01-03 |
EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director |
41,500 | $0 | 41,500 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:04 pm |
2026-01-03 2035-01-03 |
EyePoint Pharmaceuticals Inc. | EYPT | Duty Stuart Director |
40,000 | $0 | 40,000 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:04 pm |
2026-01-03 2035-01-03 |
EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director |
40,000 | $0 | 40,000 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Ribeiro Ramiro Chief Medical Officer |
176,000 | $0 | 176,000 (Direct) |
View |
2025-01-05 Exercise |
2025-01-07 4:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
30,285 | $0 | 304,281 (Direct) |
View |
2025-01-05 Tax Withholding |
2025-01-07 4:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
5,267 | $8.26 | 304,281 (Direct) |
View |
2025-01-06 Tax Withholding |
2025-01-07 4:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
4,808 | $8.68 | 304,281 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
176,000 | $0 | 304,281 (Direct) |
View |
2025-01-05 Exercise |
2025-01-07 4:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director |
87,801 | $0 | 452,791 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:04 pm |
2026-01-03 2035-01-03 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director |
40,000 | $0 | 452,791 (Direct) |
View |
2025-01-05 Exercise |
2025-01-07 4:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
10,000 | $0 | 61,400 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:04 pm |
2026-01-03 2035-01-03 |
EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director |
40,000 | $0 | 61,400 (Direct) |
View |
2025-01-05 Exercise |
2025-01-07 4:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
50,794 | $0 | 812,746 (Direct) |
View |
2025-01-05 Tax Withholding |
2025-01-07 4:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
10,007 | $8.26 | 812,746 (Direct) |
View |
2025-01-06 Tax Withholding |
2025-01-07 4:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
6,108 | $8.68 | 812,746 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
585,000 | $0 | 812,746 (Direct) |
View |
2024-09-03 Option Award |
2024-09-05 4:02 pm |
N/A 2034-09-03 |
EyePoint Pharmaceuticals Inc. | EYPT | Hassan Fred Director |
60,000 | $0 | 60,000 (Direct) |
View |
2024-07-26 Gift |
2024-07-26 4:47 pm |
N/A 2030-02-28 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director |
262,574 | $0 | 1,045,966 (Direct) |
View |
2024-07-12 Exercise |
2024-07-16 4:24 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
6,525 | $3.26 | 11,625 (Direct) |
View |
2024-07-12 Exercise |
2024-07-16 4:24 pm |
2024-02-23 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
9,775 | $0 | 11,625 (Direct) |
View |
2024-07-12 Exercise |
2024-07-16 4:24 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
3,250 | $3.5 | 11,625 (Direct) |
View |
2024-07-10 Exercise |
2024-07-12 5:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
16,666 | $0 | 93,861 (Direct) |
View |
2024-07-10 Tax Withholding |
2024-07-12 5:04 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
8,059 | $8.69 | 93,861 (Direct) |
View |
2024-07-10 Exercise |
2024-07-12 5:03 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
11,111 | $0 | 243,574 (Direct) |
View |
2024-07-11 Exercise |
2024-07-12 5:00 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director |
2,000 | $0 | 6,000 (Direct) |
View |
2024-06-23 Exercise |
2024-06-25 4:16 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | ADAMIS ANTHONY P Director |
2,000 | $0 | 6,000 (Direct) |
View |
2024-06-03 Exercise |
2024-06-04 4:28 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
6,525 | $3.26 | 23,250 (Direct) |
View |
2024-06-03 Exercise |
2024-06-04 4:28 pm |
2024-02-23 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
9,775 | $0 | 23,250 (Direct) |
View |
2024-06-03 Exercise |
2024-06-04 4:28 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
3,250 | $3.5 | 23,250 (Direct) |
View |
2024-05-25 Exercise |
2024-05-28 4:22 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
7,500 | $0 | 62,480 (Direct) |
View |
2024-05-25 Tax Withholding |
2024-05-28 4:22 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer |
3,627 | $11.16 | 62,480 (Direct) |
View |
2024-05-14 Exercise |
2024-05-16 5:19 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
6,525 | $3.26 | 34,875 (Direct) |
View |
2024-05-14 Exercise |
2024-05-16 5:19 pm |
2024-02-23 2033-06-19 |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
9,775 | $0 | 34,875 (Direct) |
View |
2024-05-14 Exercise |
2024-05-16 5:19 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director |
3,250 | $3.5 | 34,875 (Direct) |
View |
Ownership |
2024-04-22 4:15 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Adage Capital Management L.P. Atchinson Robert Gross Phillip 10% Owner |
0 | $0 | 5,156,299 (Indirect) |
View |
2024-03-30 Exercise |
2024-04-02 5:27 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
50,404 | $0 | 67,080 (Direct) |
View |
2024-03-30 Tax Withholding |
2024-04-02 5:27 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer |
25,546 | $20.67 | 67,080 (Direct) |
View |
2024-03-01 Option Award |
2024-03-04 5:40 pm |
N/A 2034-03-01 |
EyePoint Pharmaceuticals Inc. | EYPT | Ribeiro Ramiro Chief Medical Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2024-02-27 Gift |
2024-02-28 4:46 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
2,500 | $0 | 51,920 (Direct) |
View |
2024-02-20 Gift |
2024-02-22 5:08 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO |
20,000 | $0 | 51,920 (Direct) |
View |
2024-02-09 Exercise |
2024-02-13 5:40 pm |
N/A 2031-02-09 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
37,534 | $0 | 758,740 (Direct) |
View |
2024-02-09 Tax Withholding |
2024-02-13 5:40 pm |
N/A N/A |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
14,943 | $28.8 | 758,740 (Direct) |
View |
2024-02-13 Gift |
2024-02-13 5:40 pm |
N/A 2030-02-28 |
EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair |
99,817 | $0 | 758,740 (Direct) |
View |